5-hydroxymethylcytosine

References

• Lim DH, Maher ER. Genomic imprinting syndromes and cancer. Adv Genet 2010; 70:145 - 75; http://dx.doi.org/10.1016/B978-0-12-380866-0.60006-X; PMID: 20920748
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683 - 92; http://dx.doi.org/10.1016/j.cell.2007.01.029; PMID: 17320506
   PubMed Web of Science ®Google Scholar
• Grønbaek K, Hother C, Jones PA. Epigenetic changes in cancer. APMIS 2007; 115:1039 - 59; http://dx.doi.org/10.1111/j.1600-0463.2007.apm_636.xml.x; PMID: 18042143
   PubMed Web of Science ®Google Scholar
• Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009; 324:929 - 30; http://dx.doi.org/10.1126/science.1169786; PMID: 19372393
   PubMed Web of Science ®Google Scholar
• Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324:930 - 5; http://dx.doi.org/10.1126/science.1170116; PMID: 19372391
   PubMed Web of Science ®Google Scholar
• Wyatt GR, Cohen SS. A new pyrimidine base from bacteriophage nucleic acids. Nature 1952; 170:1072 - 3; http://dx.doi.org/10.1038/1701072a0; PMID: 13013321
   PubMed Web of Science ®Google Scholar
• Penn NW, Suwalski R, O’Riley C, Bojanowski K, Yura R. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem J 1972; 126:781 - 90; PMID: 4538516
   PubMed Web of Science ®Google Scholar
• Wu H, D’Alessio AC, Ito S, Wang Z, Cui K, Zhao K, Sun YE, Zhang Y. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev 2011; 25:679 - 84; http://dx.doi.org/10.1101/gad.2036011; PMID: 21460036
   PubMed Web of Science ®Google Scholar
• Pastor WA, Pape UJ, Huang Y, Henderson HR, Lister R, Ko M, McLoughlin EM, Brudno Y, Mahapatra S, Kapranov P, et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 2011; 473:394 - 7; http://dx.doi.org/10.1038/nature10102; PMID: 21552279
   PubMed Web of Science ®Google Scholar
• Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, Hore TA, Marques CJ, Andrews S, Reik W. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011; 473:398 - 402; http://dx.doi.org/10.1038/nature10008; PMID: 21460836
   PubMed Web of Science ®Google Scholar
• Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen SE. 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol 2011; 12:R54; http://dx.doi.org/10.1186/gb-2011-12-6-r54; PMID: 21689397
   PubMed Web of Science ®Google Scholar
• Globisch D, Münzel M, Müller M, Michalakis S, Wagner M, Koch S, Brückl T, Biel M, Carell T. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 2010; 5:e15367; http://dx.doi.org/10.1371/journal.pone.0015367; PMID: 21203455
   PubMed Web of Science ®Google Scholar
• Song CX, Szulwach KE, Fu Y, Dai Q, Yi C, Li X, Li Y, Chen CH, Zhang W, Jian X, et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol 2011; 29:68 - 72; http://dx.doi.org/10.1038/nbt.1732; PMID: 21151123
   PubMed Web of Science ®Google Scholar
• Li W, Liu M. Distribution of 5-hydroxymethylcytosine in different human tissues. J Nucleic Acids 2011; 2011:870726; http://dx.doi.org/10.4061/2011/870726; PMID: 21772996
   PubMedGoogle Scholar
• Nestor CE, Ottaviano R, Reddington J, Sproul D, Reinhardt D, Dunican D, Katz E, Dixon JM, Harrison DJ, Meehan RR. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res 2012; 22:467 - 77; http://dx.doi.org/10.1101/gr.126417.111; PMID: 22106369
   PubMed Web of Science ®Google Scholar
• Ito S, D’Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010; 466:1129 - 33; http://dx.doi.org/10.1038/nature09303; PMID: 20639862
   PubMed Web of Science ®Google Scholar
• Thalhammer A, Hansen AS, El-Sagheer AH, Brown T, Schofield CJ. Hydroxylation of methylated CpG dinucleotides reverses stabilisation of DNA duplexes by cytosine 5-methylation. Chem Commun (Camb) 2011; 47:5325 - 7; http://dx.doi.org/10.1039/c0cc05671e; PMID: 21451870
   PubMed Web of Science ®Google Scholar
• Rougier N, Bourc’his D, Gomes DM, Niveleau A, Plachot M, Pàldi A, Viegas-Péquignot E. Chromosome methylation patterns during mammalian preimplantation development. Genes Dev 1998; 12:2108 - 13; http://dx.doi.org/10.1101/gad.12.14.2108; PMID: 9679055
   PubMed Web of Science ®Google Scholar
• Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 2007; 67:946 - 50; http://dx.doi.org/10.1158/0008-5472.CAN-06-3123; PMID: 17283125
   PubMed Web of Science ®Google Scholar
• Cannon SV, Cummings A, Teebor GW. 5-Hydroxymethylcytosine DNA glycosylase activity in mammalian tissue. Biochem Biophys Res Commun 1988; 151:1173 - 9; http://dx.doi.org/10.1016/S0006-291X(88)80489-3; PMID: 3355548
   PubMed Web of Science ®Google Scholar
• Zhang P, Su L, Wang Z, Zhang S, Guan J, Chen Y, Yin Y, Gao F, Tang B, Li Z. The involvement of 5-hydroxymethylcytosine in active DNA demethylation in mice. Biol Reprod 2012; 86:104; http://dx.doi.org/10.1095/biolreprod.111.096073; PMID: 22262693
   PubMed Web of Science ®Google Scholar
• Jin SG, Kadam S, Pfeifer GP. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res 2010; 38:e125; http://dx.doi.org/10.1093/nar/gkq223; PMID: 20371518
   PubMed Web of Science ®Google Scholar
• Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 2004; 32:4100 - 8; http://dx.doi.org/10.1093/nar/gkh739; PMID: 15302911
   PubMed Web of Science ®Google Scholar
• Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16:6 - 21; http://dx.doi.org/10.1101/gad.947102; PMID: 11782440
   PubMed Web of Science ®Google Scholar
• Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10:295 - 304; http://dx.doi.org/10.1038/nrg2540; PMID: 19308066
   PubMed Web of Science ®Google Scholar
• Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 2008; 9:465 - 76; http://dx.doi.org/10.1038/nrg2341; PMID: 18463664
   PubMed Web of Science ®Google Scholar
• Privat E, Sowers LC. Photochemical deamination and demethylation of 5-methylcytosine. Chem Res Toxicol 1996; 9:745 - 50; http://dx.doi.org/10.1021/tx950182o; PMID: 8831819
   PubMed Web of Science ®Google Scholar
• Adams TB, Hallagan JB, Putnam JM, Gierke TL, Doull J, Munro IC, Newberne P, Portoghese PS, Smith RL, Wagner BM, et al. The FEMA GRAS assessment of alicyclic substances used as flavour ingredients. Food Chem Toxicol 1996; 34:763 - 828; http://dx.doi.org/10.1016/S0278-6915(96)00051-8; PMID: 8972877
   PubMed Web of Science ®Google Scholar
• Xu Y, Wu F, Tan L, Kong L, Xiong L, Deng J, Barbera AJ, Zheng L, Zhang H, Huang S, et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 2011; 42:451 - 64; http://dx.doi.org/10.1016/j.molcel.2011.04.005; PMID: 21514197
   PubMed Web of Science ®Google Scholar
• Iyer LM, Tahiliani M, Rao A, Aravind L. Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle 2009; 8:1698 - 710; http://dx.doi.org/10.4161/cc.8.11.8580; PMID: 19411852
   PubMed Web of Science ®Google Scholar
• Loenarz C, Schofield CJ. Oxygenase catalyzed 5-methylcytosine hydroxylation. Chem Biol 2009; 16:580 - 3; http://dx.doi.org/10.1016/j.chembiol.2009.06.002; PMID: 19549596
   PubMed Web of Science ®Google Scholar
• Long HK, Blackledge NP, Klose RJ. ZF-CxxC domain-containing proteins, CpG islands and the chromatin connection. Biochem Soc Trans 2013; 41:727 - 40; http://dx.doi.org/10.1042/BST20130028; PMID: 23697932
   PubMed Web of Science ®Google Scholar
• Koh KP, Yabuuchi A, Rao S, Huang Y, Cunniff K, Nardone J, Laiho A, Tahiliani M, Sommer CA, Mostoslavsky G, et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011; 8:200 - 13; http://dx.doi.org/10.1016/j.stem.2011.01.008; PMID: 21295276
   PubMed Web of Science ®Google Scholar
• Dawlaty MM, Ganz K, Powell BE, Hu YC, Markoulaki S, Cheng AW, Gao Q, Kim J, Choi SW, Page DC, et al. Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 2011; 9:166 - 75; http://dx.doi.org/10.1016/j.stem.2011.07.010; PMID: 21816367
   PubMed Web of Science ®Google Scholar
• Ko M, Bandukwala HS, An J, Lamperti ED, Thompson EC, Hastie R, Tsangaratou A, Rajewsky K, Koralov SB, Rao A. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc Natl Acad Sci U S A 2011; 108:14566 - 71; http://dx.doi.org/10.1073/pnas.1112317108; PMID: 21873190
   PubMed Web of Science ®Google Scholar
• Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing JR. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 2003; 17:637 - 41; http://dx.doi.org/10.1038/sj.leu.2402834; PMID: 12646957
   PubMed Web of Science ®Google Scholar
• Langemeijer SM, Aslanyan MG, Jansen JH. TET proteins in malignant hematopoiesis. Cell Cycle 2009; 8:4044 - 8; http://dx.doi.org/10.4161/cc.8.24.10239; PMID: 19923888
   PubMed Web of Science ®Google Scholar
• Ko M, An J, Bandukwala HS, Chavez L, Aijö T, Pastor WA, Segal MF, Li H, Koh KP, Lähdesmäki H, et al. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature 2013; 497:122 - 6; http://dx.doi.org/10.1038/nature12052; PMID: 23563267
   PubMed Web of Science ®Google Scholar
• Xu Y, Xu C, Kato A, Tempel W, Abreu JG, Bian C, Hu Y, Hu D, Zhao B, Cerovina T, et al. Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for Xenopus eye and neural development. Cell 2012; 151:1200 - 13; http://dx.doi.org/10.1016/j.cell.2012.11.014; PMID: 23217707
   PubMed Web of Science ®Google Scholar
• Deplus R, Delatte B, Schwinn MK, Defrance M, Méndez J, Murphy N, Dawson MA, Volkmar M, Putmans P, Calonne E, et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J 2013; 32:645 - 55; http://dx.doi.org/10.1038/emboj.2012.357; PMID: 23353889
   PubMed Web of Science ®Google Scholar
• Chen Q, Chen Y, Bian C, Fujiki R, Yu X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 2013; 493:561 - 4; http://dx.doi.org/10.1038/nature11742; PMID: 23222540
   PubMed Web of Science ®Google Scholar
• Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301:89 - 92; http://dx.doi.org/10.1038/301089a0; PMID: 6185846
   PubMed Web of Science ®Google Scholar
• Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 1983; 11:6883 - 94; http://dx.doi.org/10.1093/nar/11.19.6883; PMID: 6314264
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415 - 28; PMID: 12042769
   PubMed Web of Science ®Google Scholar
• Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349:2042 - 54; http://dx.doi.org/10.1056/NEJMra023075; PMID: 14627790
   PubMed Web of Science ®Google Scholar
• Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005; 5:223 - 31; http://dx.doi.org/10.1038/nrc1571; PMID: 15719030
   PubMed Web of Science ®Google Scholar
• Sun L, Hui AM, Kanai Y, Sakamoto M, Hirohashi S. Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis. Jpn J Cancer Res 1997; 88:1165 - 70; http://dx.doi.org/10.1111/j.1349-7006.1997.tb00345.x; PMID: 9473734
   PubMedGoogle Scholar
• Peng DF, Kanai Y, Sawada M, Ushijima S, Hiraoka N, Kosuge T, Hirohashi S. Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci 2005; 96:403 - 8; http://dx.doi.org/10.1111/j.1349-7006.2005.00071.x; PMID: 16053511
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Kanai Y, Saito Y, Kitamura T, Kakizoe T, Hirohashi S. Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder. J Urol 2003; 170:2463 - 6; http://dx.doi.org/10.1097/01.ju.0000095919.50869.c9; PMID: 14634451
   PubMed Web of Science ®Google Scholar
• Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012; 150:1135 - 46; http://dx.doi.org/10.1016/j.cell.2012.07.033; PMID: 22980977
   PubMed Web of Science ®Google Scholar
• Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010; 18:553 - 67; http://dx.doi.org/10.1016/j.ccr.2010.11.015; PMID: 21130701
   PubMed Web of Science ®Google Scholar
• Minor EA, Court BL, Young JI, Wang G. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J Biol Chem 2013; 288:13669 - 74; http://dx.doi.org/10.1074/jbc.C113.464800; PMID: 23548903
   PubMed Web of Science ®Google Scholar
• Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res 2002; 62:4075 - 80; PMID: 12124344
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 2009; 114:144 - 7; http://dx.doi.org/10.1182/blood-2009-03-210039; PMID: 19420352
   PubMed Web of Science ®Google Scholar
• Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, An J, Lamperti ED, Koh KP, Ganetzky R, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010; 468:839 - 43; http://dx.doi.org/10.1038/nature09586; PMID: 21057493
   PubMed Web of Science ®Google Scholar
• Pronier E, Almire C, Mokrani H, Vasanthakumar A, Simon A, da Costa Reis Monte Mor B, Massé A, Le Couédic JP, Pendino F, Carbonne B, et al. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors. Blood 2011; 118:2551 - 5; http://dx.doi.org/10.1182/blood-2010-12-324707; PMID: 21734233
   PubMed Web of Science ®Google Scholar
• Albano F, Anelli L, Zagaria A, Coccaro N, Minervini A, Rossi AR, Specchia G. Decreased TET2 gene expression during chronic myeloid leukemia progression. Leuk Res 2011; 35:e220 - 2; http://dx.doi.org/10.1016/j.leukres.2011.07.013; PMID: 21794915
   PubMed Web of Science ®Google Scholar
• Pérez C, Martínez-Calle N, Martín-Subero JI, Segura V, Delabesse E, Fernandez-Mercado M, Garate L, Alvarez S, Rifon J, Varea S, et al. TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia. PLoS One 2012; 7:e31605; http://dx.doi.org/10.1371/journal.pone.0031605; PMID: 22328940
   PubMed Web of Science ®Google Scholar
• Mancini M, Veljkovic N, Leo E, Aluigi M, Borsi E, Galloni C, Iacobucci I, Barbieri E, Santucci MA. Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia. J Cell Biochem 2012; 113:2765 - 74; http://dx.doi.org/10.1002/jcb.24154; PMID: 22467095
   PubMed Web of Science ®Google Scholar
• Li Z, Cai X, Cai CL, Wang J, Zhang W, Petersen BE, Yang FC, Xu M. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 2011; 118:4509 - 18; http://dx.doi.org/10.1182/blood-2010-12-325241; PMID: 21803851
   PubMed Web of Science ®Google Scholar
• Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS One 2012; 7:e41036; http://dx.doi.org/10.1371/journal.pone.0041036; PMID: 22829908
   PubMed Web of Science ®Google Scholar
• Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y, Schackert G, Krex D, Lu Q, Pfeifer GP. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res 2011; 71:7360 - 5; http://dx.doi.org/10.1158/0008-5472.CAN-11-2023; PMID: 22052461
   PubMed Web of Science ®Google Scholar
• Shih AH, Levine RL. IDH1 mutations disrupt blood, brain, and barriers. Cancer Cell 2012; 22:285 - 7; http://dx.doi.org/10.1016/j.ccr.2012.08.022; PMID: 22975371
   PubMed Web of Science ®Google Scholar
• Kraus TF, Globisch D, Wagner M, Eigenbrod S, Widmann D, Münzel M, Müller M, Pfaffeneder T, Hackner B, Feiden W, et al. Low values of 5-hydroxymethylcytosine (5hmC), the “sixth base,” are associated with anaplasia in human brain tumors. Int J Cancer 2012; 131:1577 - 90; http://dx.doi.org/10.1002/ijc.27429; PMID: 22234893
   PubMed Web of Science ®Google Scholar
• Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y, Ijichi H, Nagae G, Yoshida H, Aburatani H, Koike K. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 2012; 103:670 - 6; http://dx.doi.org/10.1111/j.1349-7006.2012.02213.x; PMID: 22320381
   PubMed Web of Science ®Google Scholar
• Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, Toubaji A, Argani P, Iacobuzio-Donahue C, Nelson WG, et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011; 2:627 - 37; PMID: 21896958
   PubMed Web of Science ®Google Scholar
• Tan L, Shi YG. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 2012; 139:1895 - 902; http://dx.doi.org/10.1242/dev.070771; PMID: 22569552
   PubMed Web of Science ®Google Scholar